Pharma Equity Group A/s Aktie - 0REU

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

0,40

Gebot

0,00

Fragen

0,00

Volumen

0,00

0,00 Tagesbereich 0,00

0,40 52-Wochen-Bereich 0,40

Marktkapitalisierung

409,186M

Handelsende

0,40

Handelsbeginn

Letzte Trade

(O)

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

0,00

Ausgegebene Aktien

1.022.964.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

-16,60

Gewinn pro Aktie (EPS)

-0,02

Erlöse

Nettogewinn

-24,61M

Sektor

Investors, Nec

Branche

Money Management

Website

www.blue-vision.dk

Hauptsitz

Copenhagen, Dnk

Gegründet

2002

Pharma Equity Group A/s is listed in the Investors sector of the Londoner Börse with ticker 0REU. The last closing price for Pharma Equity Group A/s was kr0,40. Over the last year, Pharma Equity Group A/s shares have traded in a share price range of kr 0,40 to kr 0,40.

Pharma Equity Group A/s currently has 1.022.964.000 shares in issue. The market capitalisation of Pharma Equity Group A/s is kr409,19 million. Pharma Equity Group A/s has a price to earnings ratio (PE ratio) of -16.60.

Pharma Equity Group 2025 Financial Calendar

Pharma Equity Group 2025 Financial Calendar 14 January 2025 News Release Pharma Equity Group2025 Financial Calendar March 4Deadline for shareholder proposals - Annual General meeting March 20...

The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.

The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. The Board of Directors' decision on a new execution...

Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S

Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S...

Consolidated Interim report 1 January – 30 September 2024

Consolidated Interim report 1 January – 30 September 2024 Consolidated Interim report 1 January – 30 September 2024 Company announcement no. 30 – November 15, 2024 Key points from the Q1-Q3-2024...

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. Pharma Equity Group's...

Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights

Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights Registration of capital reduction by way of a...

Zeitraum †	Handelsbeginn	Hoch	Niedrig
1	0.4	0.4	0.4	DE
4	0.4	0.4	0.4	DE
12	0.4	0.4	0.4	DE
26	0.4	0.4	0.4	DE
52	0.4	0.4	0.4	DE
156	0.4	0.4	0.4	DE
260	0.4	0.4	0.4	DE

0REU - Frequently Asked Questions (FAQ)

What is the current Pharma Equity Group A/s share price?

The current share price of Pharma Equity Group A/s is kr 0,40

How many Pharma Equity Group A/s shares are in issue?

Pharma Equity Group A/s has 1.022.964.000 shares in issue

What is the market cap of Pharma Equity Group A/s?

The market capitalisation of Pharma Equity Group A/s is DKK 409,19M

What is the 1 year trading range for Pharma Equity Group A/s share price?

Pharma Equity Group A/s has traded in the range of kr 0,40 to kr 0,40 during the past year

What is the PE ratio of Pharma Equity Group A/s?

The price to earnings ratio of Pharma Equity Group A/s is -16,6

What is the reporting currency for Pharma Equity Group A/s?

Pharma Equity Group A/s reports financial results in DKK

What is the latest annual profit for Pharma Equity Group A/s?

The latest annual profit of Pharma Equity Group A/s is DKK -24,61M

What is the registered address of Pharma Equity Group A/s?

The registered address for Pharma Equity Group A/s is VESTER FARIMAGSGADE 1, 2, COPENHAGEN, DK-2900

What is the Pharma Equity Group A/s website address?

The website address for Pharma Equity Group A/s is www.blue-vision.dk

Which industry sector does Pharma Equity Group A/s operate in?

Pharma Equity Group A/s operates in the MONEY MANAGEMENT sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GENIGenincode Plc	5,25p (64,06%)	21,13M
EMEEmpyrean Energy Plc	0,1175p (46,88%)	1,13B
WJGWatkin Jones Plc	24,95p (25,76%)	12,89M
IMMImmupharma Plc	3,50p (23,46%)	5,92M
CLAICel Ai Plc	0,38p (22,58%)	26,22M
PPSProton Motor Power Systems Plc	0,175p (-41,67%)	1,53M
ENWEnwell Energy Plc	17,50p (-25,53%)	238,06k
QBTQuantum Blockchain Technologies Plc	1,185p (-24,76%)	135,93M
MILAMila Resources Plc	0,175p (-22,22%)	19,06M
REVBRevolution Beauty Group Plc	11,00p (-22,10%)	7,46M
SYMESupply@me Capital Plc	0,0027p (-8,47%)	1,31B
EMEEmpyrean Energy Plc	0,1175p (46,88%)	1,13B
NTVONativo Resources Plc	0,0021p (5,00%)	862,02M
TM1Technology Minerals Plc	0,13p (-8,96%)	420,61M
TRPTower Resources Plc	0,0275p (-6,78%)	365,24M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pharma Equity Group A/s (0REU)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Pharma Equity Group A/s

0REU Neueste Nachrichten

Pharma Equity Group 2025 Financial Calendar

The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.

Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S

Consolidated Interim report 1 January – 30 September 2024

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Major shareholder announcement - Pharma Equity Group A/S

Managers’ transactions

Pharma Equity Group announces successful completion of directed issue of new shares

Pharma Equity Group announces issuance of new shares in a direct issue

Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights

Pharma Equity Group 2025 Financial Calendar

The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S.

Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S

Consolidated Interim report 1 January – 30 September 2024

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051.

Major shareholder announcement - Pharma Equity Group A/S

Managers’ transactions

Pharma Equity Group announces successful completion of directed issue of new shares

0REU - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Handelsbeginn	Hoch	Niedrig
1	0.4	0.4	0.4	DE
4	0.4	0.4	0.4	DE
12	0.4	0.4	0.4	DE
26	0.4	0.4	0.4	DE
52	0.4	0.4	0.4	DE
156	0.4	0.4	0.4	DE
260	0.4	0.4	0.4	DE

Zeitraum †	Handelsbeginn	Hoch	Niedrig
1	0.4	0.4	0.4	DE
4	0.4	0.4	0.4	DE
12	0.4	0.4	0.4	DE
26	0.4	0.4	0.4	DE
52	0.4	0.4	0.4	DE
156	0.4	0.4	0.4	DE
260	0.4	0.4	0.4	DE

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pharma Equity Group A/s (0REU) Börsenkurse

Pharma Equity Group A/s (0REU)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Pharma Equity Group A/s

0REU Neueste Nachrichten

0REU - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Handelsbeginn	Hoch	Niedrig
1	0.4	0.4	0.4	DE
4	0.4	0.4	0.4	DE
12	0.4	0.4	0.4	DE
26	0.4	0.4	0.4	DE
52	0.4	0.4	0.4	DE
156	0.4	0.4	0.4	DE
260	0.4	0.4	0.4	DE